Isoxsuprine%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a peripheral vasodilator. Its exact mechanism of action is not fully understood, but it is thought to relax vascular smooth muscle, leading to vasodilation and improved blood flow. ## Primary Indications * Peripheral vascular disease, such as intermittent claudication. * Cerebrovascular insufficiency. ## Adult Dosing * **Intermittent Claudication/Peripheral Vascular Disease:** 10-20 mg orally 3-4 times daily. * **Cerebrovascular Insufficiency:** 10-20 mg orally 3-4 times daily. Dose titration may be necessary. Maximum daily dose is generally 80 mg. Specific dosing may vary based on local protocol. ## Pediatric Dosing There is no established pediatric dosing for isoxsuprine hydrochloride. Use is generally not recommended in pediatric patients. ## Dose Adjustments No specific dose adjustments are typically required for renal or hepatic impairment. However, caution and close monitoring are advised in patients with pre-existing cardiovascular conditions. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Use in patients with congenital heart defects. * Use in patients with recent myocardial infarction. * Use in patients with arrhythmias. ## Adverse Effects * **Common:** Nausea, vomiting, gastric distress, dizziness, weakness, flushing, hypotension, tachycardia. * **Less Common:** Rash, drowsiness, nervousness, stomach cramps, shortness of breath, chest pain. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. Monitor blood pressure closely. * **Other Vasodilators:** Concurrent use with other vasodilators may increase the risk of hypotension. ## Monitoring * Blood pressure and heart rate. * Symptoms of peripheral vascular disease (e.g., claudication distance). * Signs of adverse effects. ## Clinical Pearls * Isoxsuprine's efficacy in treating peripheral vascular disease is controversial, and it is not universally accepted as a first-line treatment. * Benefits may not be apparent for several weeks after initiating therapy. * Patients should be advised to report any adverse effects, especially cardiovascular symptoms. *** *This information is intended for healthcare professionals and does not replace the need to consult the most current prescribing information and professional judgment.*